D. Deng

发表

Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus

Ying Wang, Liangdan Sun, H. Zheng, 2009, Nature Genetics.

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis

Ping Liu, H. Yang, Hong-Fu Xie, 2016, Chinese medical journal.

A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum

G. Ling, Q. Guo, Lingyun Sun, 2020, Lupus.

Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review

D. Deng, Pei-lian Zhang, Jianping Xu, 2016, Emerging microbes & infections.

Cryptococcosis in patients with diabetes mellitus II in mainland China: 1993‐2015

D. Deng, Jianping Xu, T. Boekhout, 2017, Mycoses.

Effects of Cigarette Smoke Extracts on the Growth and Senescence of Skin Fibroblasts In Vitro

D. Deng, Chun-Lei Zhang, Gao-yun Yang, 2013, International journal of biological sciences.

Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population

D. Deng, Binbin Yang, Wei Zhang, 2020, Clinical Rheumatology.

A Case of Cutaneous Nocardiosis with Involvement of the Trachea, Anterior Mediastinum and Sternum

D. Deng, Yun Guo, Xiaoyun Wang, 2010, Case Reports in Dermatology.

Transplantation of human umbilical cord mesenchymal stem cell relieves the symptoms of lupus nephritis by inhibiting osteopontin expression

D. Deng, Pei-lian Zhang, Yun Guo, 2017 .

Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study

Jinhua Xu, D. Deng, Linfeng Li, 2019, Artificial cells, nanomedicine, and biotechnology.

Prevalence of photodermatosis in four regions at different altitudes in Yunnan province, China

D. Deng, Hanying Li, Hao Chen, 2006, The Journal of dermatology.

miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG.

D. Deng, Xin Liu, Guilan Hu, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tuberculosis/cryptococcosis co-infection in China between 1965 and 2016

D. Denning, D. Deng, Jianping Xu, 2017, Emerging Microbes &Infections.

Response to: ’Umbilical-cord messenchymal stem cells for the treatment of automimmune diseases: beware of cell to cell contact' by Alunno et al

D. Deng, Pei-lian Zhang, T. Lim, 2017, Annals of the rheumatic diseases.

Evaluation of two molecular techniques for rapid detection of the main dermatophytic agents of tinea capitis

D. Deng, S. Deng, W. Liao, 2015, The British journal of dermatology.

Comparison of the In Vitro Activities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum

S. Seyedmousavi, D. Deng, S. Deng, 2015, Antimicrobial Agents and Chemotherapy.

Severe Chromoblastomycosis-Like Cutaneous Infection Caused by Chrysosporium keratinophilum

D. Deng, Pei-lian Zhang, S. de Hoog, 2017, Front. Microbiol..

Nocardia colli sp. nov., a new pathogen isolated from a patient with primary cutaneous nocardiosis

D. Deng, Pei-lian Zhang, Xiao-lan Li, 2020, International journal of systematic and evolutionary microbiology.

Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus

D. Deng, P. Zhang, Y. Guo, 2019, Lupus.

Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences

D. Deng, H. Xie, G. Qian, 2014, Lupus.

The analysis of acne increasing suicide risk

D. Deng, Binbin Yang, Yun Zhu, 2021, Medicine.

A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis

D. Deng, Pei-lian Zhang, T. Lim, 2017, Annals of the rheumatic diseases.

A Multimodal Deep Learning-based Platform that Assists in the Classification of Lupus Subtypes and Differential Diagnosis Among Lupus and Other Similar Skin Diseases

Haoran Hu, Jianyun Lu, Q. Lu, 2021 .

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

Qiu-Ning Sun, Q. Lu, D. Deng, 2020, Chinese medical journal.

Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2

D. Deng, Binbin Yang, Xinwei Huang, 2021, Frontiers in Immunology.

Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.

Kehu Yang, Q. Guo, Q. Lu, 2021, Journal of autoimmunity.

TNF-238A is associated with juvenile onset psoriasis in patients of Han population in Southwest China.

Ya-ping Zhang, D. Deng, Chang Sun, 2004, Journal of dermatological science.

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Q. Guo, Xinghua Gao, D. Deng, 2021, Advances in Therapy.

Targeting of EIF4EBP1 by miR‐99a‐3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression

D. Deng, Binbin Yang, Mengsu Yang, 2021, Journal of Cellular and Molecular Medicine.

Is the step‐up therapy of topical 5‐aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart?

D. Deng, Sisi Wang, Gao-yun Yang, 2014, Dermatologic therapy.

Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China

Q. Lu, D. Deng, Peng Zhang, 2023, Lupus Science & Medicine.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.